Stock Analysis

Option Care Health First Quarter 2024 Earnings: Beats Expectations

NasdaqGS:OPCH
Source: Shutterstock

Option Care Health (NASDAQ:OPCH) First Quarter 2024 Results

Key Financial Results

  • Revenue: US$1.15b (up 13% from 1Q 2023).
  • Net income: US$44.8m (up 14% from 1Q 2023).
  • Profit margin: 3.9% (in line with 1Q 2023).
  • EPS: US$0.26 (up from US$0.22 in 1Q 2023).
earnings-and-revenue-growth
NasdaqGS:OPCH Earnings and Revenue Growth April 26th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Option Care Health Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 4.0%. Earnings per share (EPS) also surpassed analyst estimates by 16%.

Looking ahead, revenue is forecast to grow 8.4% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Healthcare industry in the US.

Performance of the American Healthcare industry.

The company's shares are down 5.2% from a week ago.

Valuation

Our analysis of these results suggests Option Care Health may be undervalued based on 6 important criteria we look at. You can access our in-depth analysis and discover what the outlook is like for the stock by clicking here.

Valuation is complex, but we're helping make it simple.

Find out whether Option Care Health is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.